Free Trial

Gabelli Funds LLC Has $15.03 Million Holdings in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Gabelli Funds LLC reduced its holdings in Procter & Gamble by 5.1%, bringing its total to 88,194 shares worth approximately $15.03 million.
  • Procter & Gamble's recent earnings report showed $1.48 earnings per share, exceeding expectations, with a 1.7% year-over-year revenue increase to $20.89 billion.
  • Institutional investors currently own 65.77% of Procter & Gamble's stock, reflecting significant investment interest from large funds.
  • Looking to export and analyze Procter & Gamble data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Gabelli Funds LLC cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 88,194 shares of the company's stock after selling 4,700 shares during the period. Gabelli Funds LLC's holdings in Procter & Gamble were worth $15,030,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in PG. Nuveen LLC bought a new stake in shares of Procter & Gamble in the 1st quarter valued at $1,954,941,000. GAMMA Investing LLC boosted its holdings in Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Invesco Ltd. raised its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after acquiring an additional 2,224,912 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Redburn Atlantic lowered Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective for the company. in a report on Thursday, May 1st. Redburn Partners set a $161.00 price objective on Procter & Gamble in a research note on Thursday, May 1st. JPMorgan Chase & Co. restated a "neutral" rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Wells Fargo & Company cut their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Finally, Piper Sandler lifted their price objective on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a report on Monday, May 5th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $175.94.

Check Out Our Latest Research Report on PG

Procter & Gamble Price Performance

Shares of NYSE PG opened at $156.96 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company's 50-day moving average is $156.63 and its 200 day moving average is $162.72. The stock has a market capitalization of $367.67 billion, a P/E ratio of 24.11, a P/E/G ratio of 4.12 and a beta of 0.37.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.

Insiders Place Their Bets

In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 119,181 shares of company stock worth $18,761,172 in the last quarter. Insiders own 0.18% of the company's stock.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines